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Abstract: The number of people in the US with opioid abuse exceeds 2 million and the total cost is 
approximately $100B per year. In this study, we focus on patient-level interventions and present three IT-based 
interventions: (a) mobile reminders, (b) electronic monitoring, and (c) composite intervention. We have 
developed an analytical model for evaluating interventions using Return-on-Investment (ROI). The 
interventions are cost-effective for higher values of intervention effectiveness, hospital, and emergency room 
cost. However, with QoL improvement, cost-effectiveness improves significantly. We also explored the use of 
financial incentives for increasing the adoption of interventions. These results will help patients, healthcare 
professionals, decision-makers, and family members to choose the most suitable intervention to address opioid 
abuse. 
 
Keywords: Opioid abuse, interventions, patient level, evaluation, analytical model 
 
INTRODUCTION 
 
Prescription opioid abuse is any intentional use of opioids outside of a physician’s prescription for a bonafide medical 
condition (Finley et al., 2017; Sinha, Jensen, Mullin, & Elkin, 2017). It can lead to addiction, higher healthcare costs, 
and serious harm to patients (Blendon & Benson, 2018). This abuse requires detoxification and hospitalization similar 
to a chronic condition. The number of people in the US with opioid abuse exceeds 2 million and the total cost is 
approximately $100B per year (NIH, 2019). According to NIH, about half of the drug overdose deaths in the US are 
due to opioids (NIH, 2019). The opioid abuse is a major challenge for patients and family members, healthcare 
professionals, employers, regulators, and the society. There is a need for interventions at multiple levels before patients 
develop opioid addiction and require major treatment. 
 
Each patient has a certain chance of abusing opioids (single vs multiple prescriptions) based on their history, genetic 
makeup, current environment, medical condition and type of opioid prescribed. Some of the patients will have low, 
some moderate and some will have high level of opioid abuse. This is also time-dependent and patients can change 
from low to moderate to high or high to moderate. This has some chance to lead to addiction, which will require 
expensive inpatient treatment. This abuse should be considered a chronic disease and different patients will require 
outpatient treatment for different duration of time. A different set of actions will be needed (a) at the source (for 
healthcare professionals) managing the prescriptions, (b) patient-level during consumption of opioids and (c) after the 
patient has developed an addiction. In this paper, we focus on patient-level interventions, which are proactive and with 
some probabilities will be effective for some patients in preventing them from developing an opioid addiction. To 
design technological interventions, we present a design approach. Using multiple constraints and considering the 
environmental context, we have developed three technological interventions.  The interventions are (a) mobile 
reminders (Voelker, 2019), (b) electronic monitoring of opioids (Jungquist et al., 2019), and (c) composite intervention 
(monitoring, reminders and support from other patients) (Schuman-Olivier et al., 2018; Varshney, 2015). The mobile 
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reminders will be sent to the patient to provide educational and motivational support to avoid overconsumption of 
opioids. The electronic monitoring will keep track of the prescribed opioids. This involves designing wireless 
monitoring systems for collecting and analyzing opioid consumption data. The composite intervention will include 
reminder, monitoring and motivational support from other patients. This intervention can reduce the consumption of 
prescription opioids by monitoring and reminding patients about taking and/or not taking certain doses within certain 
windows of time. The interventions can be implemented using both simple and sophisticated mobile apps, sensors, 
mobile devices, and smart medication boxes. This could proactively stop patients from becoming dependent on opioids 
or develop an addiction. 
 
Using prescription opioid abuse and intervention data, we derive the healthcare cost of opioid abuse along with the 
cost of three interventions. Using an analytical model and ROI (Return on Investment) as a metric for cost-
effectiveness of interventions, we derive several results for all three interventions and various levels of effectiveness. 
We found that ROI is lower than 1 for low and medium values of our parameters, while it is much more favorable 
when the values of the parameters are set to high. When the value due to a potential improvement in Quality of Life 
was included, the ROI significantly improved for all three interventions. Further, we wanted to explore if the use of 
financial incentives will be suitable to improve the adoption of three interventions. For this, we computed the 
maximum allowed financial incentives that can be offered to the patients while still meeting the cost-effectiveness 
goal for the interventions. 
 
DESIGN APPROACH 
 
The design of technological intervention starts with the identification of the environmental factors, patient’s condition 
and history followed by possible solutions. These include communication and notification with patients, observing 
consumption behavior, providing individual/group education and support, analyzing patterns of opioid consumption, 
and cognitive behavior therapy. These interventions can be single or composite (using two or more interventions). 
The interventions can be in the form of a mobile app implementing reminders, CBT, and monitoring functions. The 
composite intervention can include group support. All interventions can include analytics to study effectiveness of 
interventions. The interventions can be personalized to improve suitability to different patients and reduce the overall 
cost. If an intervention is not working as desired, it can be changed to the more desirable intervention. This entire 
process is shown in Figure 1. 
 
 
INTERVENTIONS 
 
In this study, we consider three interventions for managing opioid abuse. These interventions are based on (a) mobile 
reminders, (b) electronic monitoring and (c) combined reminders and group support from other patients. The 
interventions, termed INTV1, INTV2, and INTV3, are shown in Figure 2. INTV1 is based on reminders and can be 
supported by a mobile application or specialized software on a mobile device. INTV2 is based on communication with 
a smart medication box that keeps track of doses and timing. INTV3 can be supported by a website that allows patients 
to interact with one another and also receive educational information related to their specific conditions.  
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Figure 1: The Design Approach for Technological Interventions 
 
 
 
Figure 2: Three Interventions for Preventing Prescription Opioid Abuse 
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The Figure 3 shows the operationalization of the intervention 1. This includes sending a reminder to patient at the 
prescribed time if the patient has not taken the dose already. As shown in Figure 3(a), the reminder app (Rem-App) 
sends a message to the patient to take the opioid dose within the time-window. The app also tells the patient to wait 
for the next dose until the next reminder. Finally, the Rem-App detects the patient’s mood for its context-aware 
operation. As shown in Figure 3(b), the CBT-OP helps patient on the potential side effects of the opioids, motivation 
for exercise, healthy eating habits, managing stress, and keeping doctor’s appointment. It asks healthcare professionals 
(HP) to intervene if doses taken too closely or more frequently or more doses at a time than prescribed (analysis of 
consumption patterns). 
 
 
 
(a) Rem-App: App for Reminder 
 
 
 
 
 
(b) CBT-OP: Cognitive Behavior Therapy for Opioids 
 
Figure 3: Operationalization of Intervention 1 (Context-aware Reminders) 
The Figure 4 shows the operationalization of the intervention 2. The prescription opioid app (PO-App) retrieves dosing 
consumption data from the smart medication box. The consumption history is analyzed by the PO-App and if any 
abnormal patterns or behaviors are found then the healthcare professionals are contacted for a suitable intervention. 
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PO-App: Prescription Opioids App 
Figure 4: Operationalization of Intervention 2 (Monitoring) 
The proposed interventions are compared in Table 1, based on their functions, potential strengths, and limitations. 
INTV1 will collect opioid consumption information from the patient and send the reminder to avoid overconsumption. 
The potential problems include recall bias of the patient, user interface challenges, and any reliability and access 
problems. INTV2 will monitor and analyze opioid consumption information from a smart medication box. The 
potential problems include the operation of smart medication box and network access. INTV3 requires a sophisticated 
website and highly personalized support to the patient and can be fairly complex.  
 
Table 1: Comparison of Proposed Interventions 
Intervention Functions Operation Potential Strengths Potential 
Limitations 
INTV1 
(Mobile 
Reminders) 
Simple 
Reminder 
If taken do not take the next 
dose, else if not taken please 
take it now 
Reduce 
overconsumption 
Accuracy and 
Effectiveness 
Context-aware 
Reminder 
Will only come to maintain 
the prescribed opioid dose 
Personalized Complexity 
INTV2 
(Electronic 
Monitoring) 
Electronic 
Monitoring 
Monitoring and analyzing 
opioid consumption and 
necessary intervention 
Works with Smart 
Medication Boxes and 
family 
members/healthcare 
professionals 
Monitoring and 
analyzing 
overhead, trying to 
reach and use the 
time of family 
member and 
healthcare 
professionals 
INTV3 
(Composite) 
Composite 
(group support, 
educational 
and reminders) 
Integrating the operations of 
INTV1, INTV2, and 
technical/behavioral 
interventions 
In addition to 
potential strengths of 
reminders and 
monitoring, effective 
due to interventions 
and support from 
patients 
The complexity of 
group support and 
composite 
intervention 
 
 
In this paper, we do not study the medical effectiveness of these three interventions, but rather focus on the cost of 
these interventions and when these interventions may be suitable. In the future, these interventions can be implemented 
and tested with real patients for improving the opioid consumption behavior. 
Transactions of the International Conference on Health Information Technology Advancement 2019                                Vol.4 No. 1 
 
 
21 
 
 
ANALYTICAL MODEL 
 
Analytical models are the representations of mechanisms that govern natural phenomena that are not fully recognized, 
controlled or understood (Tedeschi, 2006). They have become indispensable tools for policy and decision-makers and 
researchers (Tedeschi, 2006). However, certain techniques must be used to evaluate mathematical models for 
objectives, scope and assumptions, appropriateness or validation, and limitations. Essentially, the model should be 
appropriate for its intended purpose under the given conditions. The model is appropriate (Tedeschi, 2006) for 
studying opioids in chronic illnesses, where multiple opioids are used over an extended period. The interventions and 
their cost can be approximated by the model. Therefore, the model is valid and sound and does what it is supposed to 
do (Tedeschi, 2006). Further, the three steps of model validation (Hamilton, 1991): verification of the model, 
sensitivity analysis, and evaluation of the model, are performed below.  
 
The verification involved step by step checking of the model and debugging where one or more changes in inputs could 
lead to unacceptable output (Hamilton, 1991; Tedeschi, 2006). Further, the model was calibrated using values from 
other studies (AHRQ, 2014; Aroke et al., 2018; Mallow, Belk, Topmiller, & Strassels, 2018; NYState, 2018; Schuchat, 
Houry, & Guy, 2017; Vivolo-Kantor et al., 2018). The model builds upon prior models, and the results obtained from 
the model are also supported by other studies. The model was validated by testing for many known cases to verify its 
functioning. Further, the causal relationships of Opioid with pharmacy cost, hospitalization cost, emergency room and 
outpatient cost, and the intervention cost for multiple chronic conditions were utilized (AHRQ, 2014; Aroke et al., 
2018). All relationships in the model were verified and additional relationships were derived by utilizing known 
relationships.    
 
The sensitivity analysis was performed to test the behavior of every equation in the model (Hamilton, 1991). There are 
several ways to perform sensitivity analysis for mathematical models (Christopher Frey & Patil, 2002). We focused on 
the nominal range sensitivity, which works well for models where there are no significant interactions among input 
values and the ranges of plausible values can be defined (using one’s judgment or from the literature). For our model, 
we broadly defined the ranges of all input values, obtained from other studies and expanded even further to cover more 
extreme cases. The analysis included combining several input values and measuring outputs for these combinations of 
inputs. The results of such analysis are presented in the next section. This also helps in answering “what-if” questions 
such as “what if patients lived in a city where hospital costs were lower” or “what if an intervention stopped working”.  
 
The evaluation of the model was done to test the adequacy (or robustness) of the model based on the precision and 
accuracy of results (Hamilton, 1991; Tedeschi, 2006). The model is precise as it produces values that are close to one 
another in multiple iterations. The model accuracy is based on (a) known relationships and (b) calibration of results for 
decision making. To measure accuracy further, we tested our model on input data and results from (AHRQ, 2014; Aroke 
et al., 2018; Mallow et al., 2018; NYState, 2018; Schuchat et al., 2017; Vivolo-Kantor et al., 2018). We further evaluated 
our model by computing the ROI for all three interventions for low, medium, and high range of input parameters. These 
values are in close agreement, so our results on opioid abuse and healthcare cost are validated using published data, 
while other results on cost of interventions are extrapolated based on known relationships and available data from 
multiple studies.  
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Table 2: Input Parameters, Key Values and Sources 
Input Parameters Average for opioid abuse Source 
The hospitalization rate .08 per person/year (0.05 - 1)  (NYState, 2018; Schuchat et al., 2017) 
The duration of hospital stays 4.35 days (2-10 days) (Mallow et al., 2018) 
The daily cost of hospital stays $1884 per day ($1000 - $3000) (Mallow et al., 2018) 
The rate of emergency room 
visits 
0.086 person/year 
(0.05 - 1)  (Vivolo-Kantor et al., 2018) 
The cost of emergency room 
visits 
2150 
($1000 - $5000) (AHRQ, 2014) 
The outpatient visit rate 12 times a year Assumption once a month 
The cost of outpatient visits $458  ($200 - $700) (Mallow et al., 2018) 
The annual cost of brand name 
medication/polypharmacy 
$7078 
($4000 - $10000) (Aroke et al., 2018) 
The annual cost of generic 
medication 
$692 
($120 - $1000) (Aroke et al., 2018) 
Probability of brand name 
prescription 
6% 
(0-20%) (Aroke et al., 2018) 
Probability of generic 
prescription 
94% 
(80-100%) (Aroke et al., 2018) 
 
Several assumptions were made to keep the analytical model tractable and reasonably accurate (Tedeschi, 2006). The 
assumptions are: 
Assumption 1: The patients are adults and living independently. 
Assumption 2: The patients can take opioids as prescribed.  
Assumption 3: The patients are willing try one or more interventions. 
Assumption 4: It is possible to amortize the cost over multiple patients. 
These assumptions could be relaxed in future work. To improve the readability of the analytical model, the notations 
used are shown in Table 3. 
 
To develop the model, we focused on healthcare savings which can be derived using the cost of healthcare without 
intervention and cost of healthcare with intervention as shown in equation 1: 
 
𝐻𝐶ௌ௔௩௜௡௚௦ ൌ 𝐻𝐶஼௢௦௧௪௜௧௛௢௨௧ூே்௏ െ 𝐻𝐶஼௢௦௧௪௜௧௛ூே்௏       (1) 
 
As shown in equation 2, the cost of intervention per year can be given as the sum of two ratios: the ratio of fix cost to 
the number of patients amortized over the number of years intervention will be used and the ratio of variable cost to 
the number of patients. 
 
𝐼𝑁𝑇𝑉஼௢௦௧௣௘௥௒௘௔௥ ൌ ቀ ஼௢௦௧ಷ಺೉ே௉∗ே௒ோூே்௏ቁ ൅ ሺ
஼௢௦௧ೇಲೃ
ே௉ ሻ       (2) 
The probability of prescription 𝑃௉௥௘௦௖ is derived as a function of finding a doctor to prescribe opioids 
𝐷𝑜𝑐𝑡𝑜𝑟௉௥௘௦௖ை௣௜௢௜ௗ and doctor willing to prescribe ൫𝐷𝑜𝑐𝑡𝑜𝑟ௐ௜௟௟௜௡௚௉௥௘௦௖൯. Further, the probability that intervention is 
effective is a product of willingness of patient, suitability of intervention to a patient, and whether the intervention is 
accurate and reliable. 
 
𝑃ா௙௙௘௖௧௜௩௘ூே்௏ ൌ ሺ𝑃𝑎𝑡𝑖𝑒𝑛𝑡ௐ௜௟௟௜௡௚௡௘௦௦𝑃𝑎𝑡𝑖𝑒𝑛𝑡ௌ௨௜௧௔௕௜௟௜௧௬ ൈ 𝐴𝑐𝑐𝑢𝑟𝑎𝑡𝑒ூே்௏𝑅𝑒𝑙𝑖𝑎𝑏𝑙𝑒ூே்௏ሻ  (3) 
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Table 3: Notations Used in Analytical Model 
Notation Meaning 
𝐴𝑐𝑐𝑢𝑟𝑎𝑡𝑒ூே்௏ Intervention is accurate 
CMIN The cost per minute of cellphone calls 
CFHOUR-J The cost of jth hour for a family member (salary and benefits)  
𝐶𝑜𝑠𝑡ிூ௑ The fixed cost of intervention 
𝐶𝑜𝑠𝑡௏஺ோ Variable cost of intervention per year 
CPHOUR-I The cost of ith hour for healthcare professionals (salary and benefits) 
𝐶𝑆ூூାଵ The cost of switching from Ith to I+1st intervention 
𝐷𝑜𝑐𝑡𝑜𝑟௉௥௘௦௖ை௣௜௢௜ௗ Finding a doctor to prescribe opioids 
𝐷𝑜𝑐𝑡𝑜𝑟ௐ௜௟௟௜௡௚௉௥௘௦௖ Doctor willing to prescribe 
FIMAX Maximum allowed financial incentive for adoption of an intervention 
𝐻𝐶ௌ௔௩௜௡௚௦ Healthcare Savings 
𝐻𝐶஼௢௦௧௪௜௧௛௢௨௧ூே்௏ Cost of healthcare without intervention 
𝐻𝐶஼௢௦௧௪௜௧௛ூே்௏ Cost of healthcare with intervention 
𝐼𝑁𝑇𝑉஼௢௦௧௣௘௥௒௘௔௥ Cost of intervention per year 
K The duration to study the benefits of reducing opioid abuse  
NMIN-K The number of phone minutes used in the kth day  
𝑁𝑃 Number of patients 
𝑁𝑌𝑅𝐼𝑁𝑇𝑉 Number of years intervention will be used 
𝑃𝑎𝑡𝑖𝑒𝑛𝑡ௐ௜௟௟௜௡௚௡௘௦௦ Willingness of patient 
𝑃𝑎𝑡𝑖𝑒𝑛𝑡ௌ௨௜௧௔௕௜௟௜௧௬ Suitability to a patient  
𝑃஺ௗௗ௜௖௧௜௢௡ Probability of addiction 
𝑃ா௙௙௘௖௧௜௩௘ூே்௏ Probability that intervention is effective 
𝑃௉ோாௌ஼ Probability of prescription 
QALY Quality adjusted life years 
QoL Quality of Life 
𝑅𝑒𝑙𝑖𝑎𝑏𝑙𝑒ூே்௏ Intervention is reliable 
𝑅𝑂𝐼 Return of Investment 
TCI Total Cost of Intervention 
TFHOUR Total time spent by a family member 
TPHOUR Total time spent per year by healthcare professionals  
𝑇𝑜𝑡𝑎𝑙௏௔௟௨௘ The total value obtained due to intervention in 1 year 
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The cost of interventions includes the cost of training, the ongoing time cost of healthcare professionals or family 
members involved, and the cost of communications. The patient's time is not included as suggested by (Windsor et 
al., 1990). However, minutes used for cell phone calls are included in the total cost of the intervention. Thus, the 
general equation for the total cost of the intervention (TCI) can be given as: 
 
𝑇𝐶𝐼 ൌ ∑ CPୌ୓୙ୖି୍்௉ಹೀೆೃூୀଵ ൅෌ CPୌ୓୙ୖି୎ ൅்ிಹೀೆೃ௃ୀଵ ෌ N୑୍୒ି୏ ൈ 𝐶ெூே ൅ 𝐼𝑁𝑇𝑉஼௢௦௧௣௘௥௒௘௔௥஽௜௒௄ୀଵ   (4) 
 
where, TPHOUR is the total time spent per year by healthcare professionals and CPHOUR-I is the cost of ith hour for 
healthcare professionals including salary and benefits. TFHOUR and CFHOUR-J represent the same factors for a family 
member. NMIN-K is the number of phone minutes used in the kth day and CMIN is the cost per minute of a phone call. 
DiY represents the number of days in a year. CFIX is the fixed cost of intervention, such as the development cost, and 
is amortized over intervention duration and the number of patients covered. CVAR is the variable cost and can include 
maintenance cost of the intervention (such as website/servers) amortized over the number of patients. Not all 
interventions will have every cost component, but the above equation can be used to derive total cost of interventions 
for all three interventions. If the selected intervention is not effective, then the total cost of intervention also includes 
the switching cost as follows: 
 
𝑇𝐶𝐼 ൌ ෌ ሺTCI୍ ൅ 𝐶𝑆ூூାଵேିଵூୀଵ ൅ 𝑇𝐶𝐼ூூାଵሻ        (5)  
where, 𝐶𝑆ூூାଵ is the cost of switching from Ith to I+1st intervention.  
 
For an intervention to be cost-effective, the savings have to be more than the total cost of interventions (or HCSavings 
>= TCI). To quantify savings to different costs of interventions, we define Return on Investment (ROI) as the ratio of 
the product of the probability of prescription, probability of addiction, healthcare savings for addicted patient, and 
probability that intervention is effective to the cost of intervention: 
 
𝑅𝑂𝐼 ൌ ሺ𝑃௉௥௘௦௖ ൈ 𝑃஺ௗௗ௜௖௧௜௢௡ ൈ 𝐻𝐶ௌ௔௩௜௡௚௦ ൈ 𝑃ா௙௙௘௖௧௜௩௘ூே்௏ሻ/𝑇𝐶𝐼     
 (6) 
Assuming non-negative quality of improvement values, the total QALY (Quality-adjusted Life Years) gained can be 
expressed as the sum of two improvements, one due to additional years obtained and another due to quality of life 
improvement in the existing years. However, we can focus on 1-year benefit, so the QALY gained is equal to the 
Quality of Life improvement when the patient does not have opioid abuse. Thus, the total value obtained in 1 year is 
the product of cost equivalent of one QALY and the number of QALY gained due to the intervention: 
 
𝑇𝑜𝑡𝑎𝑙௏௔௟௨௘ ൌ 𝐶ொ஺௅௒ ൈ 𝑁ொ஺௅௒          (7) 
 
Now, we explore the use of financial incentive for the adoption of an intervention (not given as cash, but to meet 
insurance deductible/co-pay/out-of-pocket). The maximum value of this financial incentive over a year can be given 
as follows: 
 
𝐹𝐼ெ஺௑ ൌ ሺ𝑃௉௥௘௦௖ ൈ 𝑃஺ௗௗ௜௖௧௜௢௡ ൈ 𝐻𝐶ௌ௔௩௜௡௚௦ ൈ 𝑃ா௙௙௘௖௧௜௩௘ூே்௏ሻ െ 𝑇𝐶𝐼     (8) 
 
We are currently modeling a utility function involving personalized interventions for patients and patient’s desirability 
for the interventions and outcomes. We will also address the optimization of this utility function along with 
mathematical proofs of lemmas and theorems. This will allow our analytical model to be more generalizable. The 
QALY gained will be computed using both the utility and predicted life expectancy.  
 
RESULTS 
 
Although multiple interventions are medically suitable in preventing opioid abuse, we want to evaluate the cost of 
interventions and study when and where these interventions are cost-effective. Next, the cost components of various 
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interventions are shown in Table 4 along with the values used (BLS, 2018; Page, Horvath, Danilenko, & Williams, 
2012; Varshney, 2013). The cost of electronic monitoring is a function of the dosing frequency as additional processing 
is required from the healthcare professional every time an opioid is consumed or scheduled. Mobile reminders are the 
simplest intervention while composite intervention is likely to be most effective. The cost of the mobile application is 
varied from zero to ten dollars a month to accommodate different versions (basic, premium, deluxe) of the app. 
 
 
Table 4: The Cost Components of Various Interventions 
The 
Intervention 
Included Components Time (Total Cost) Total Cost of Intervention 
(TCI) 
(Low, Medium, High) 
INTV1: Mobile 
Reminders 
Training of a nurse 
(one-time initial cost) 
2, 3 and 4 hours 
($40, $60, $80) 
$1099, $1179, $1259 
One phone call per day 5 minutes ($1.67) 
Rest two calls as recorded 
messages 
2 minutes 
($0.67) 
Mobile App cost per month 0, $5, $10 
INTV2: Electronic 
Monitoring 
Training and installation 2, 3 and 4 hours 
($40, $60, $80) 
$1199, $1419, $1639 
Messages 2 minutes 
($0.67) 
Message Processing by a Nurse 5 minutes ($1.67) 
Cost of Monitoring 
System/Software 
$100, $300, $500 
INTV3: Composite Informational Material 
Reminder 
Group Support 
Specialized Application 
$500,000 
developmental cost 
$5000/month 
maintenance cost 
$1080 (1000 patients), 
$1453 (600 patients), 
$3320 (200 patients) 
Family/Healthcare professional 30 minutes ($20/hour cost=$10) 
 
 
The ROI for different interventions is shown in Table 5. We included low, medium and high values of parameters, to 
cover many different scenarios, in deriving ROI. The ROI is <1 (shown in red) for low and medium values of our 
input parameters, while it is much more favorable when the values of the parameters are set to high. For the same 
level of effectiveness, INTV3 is cost-effective only for 100% medical effectiveness and high value of parameters. 
 
Table 5: ROI for Various Types and Level of Intervention Effectiveness 
Effectiveness 
ROI 
INTV1 INTV2 INTV3 
Low Medium High Low Medium High Low Medium High 
25% 0.0005 0.04 0.66 0.0005 0.03 0.51 0.0005 0.03 0.25 
50% 0.001 0.08 1.32 0.0015 0.09 1.53 0.001 0.06 0.5 
75% 0.0015 0.12 1.98 0.0015 0.09 1.53 0.0015 0.09 0.75 
100% 0.002 0.16 2.64 0.002 0.12 2.04 0.002 0.12 1 
Low, Medium, and High range for following input parameters: 
Hospitalization, Number of days, Cost/day, Emergency visit rate, Emergency cost/visit, Probability of addiction 
 
Next, we decided to include the value due to a potential improvement in Quality of Life (QoL). The ROI for different 
interventions with QoL included is shown in Table 6. Now, the ROI is <1 (shown in red) only for low values of our 
parameters, while it is much more favorable (shown in green) when the values of the parameters are set to medium or 
high. 
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Table 6: ROI for Different Interventions with Quality of Life Improvement 
Effectiveness 
ROI with QoL 
INTV1 INTV2 INTV3 
Low Medium High Low Medium High Low Medium High 
25% 0.0232 0.57 2.646 0.0214 0.47 2.035 0.0236 0.4601 1.003 
50% 0.0464 1.14 5.292 0.0427 0.941 4.071 0.0473 0.9203 2.006 
75% 0.0697 1.71 7.938 0.0641 1.411 6.106 0.0709 1.38 3.009 
100% 0.0928 2.28 10.584 0.0854 1.882 8.141 0.0946 1.841 4.012 
Low, Medium, and High range for following input parameters: 
Hospitalization, Number of days, Cost/day, Emergency visit rate, Emergency cost/visit, Probability of addiction, QoL 
 
Next, we decided to add a financial incentive (not cash, but payment for insurance deductible, out-of-pocket expenses 
or co-pay for general healthcare and wellness) to improve the adoption of three interventions by patients. We wanted 
to compute the maximum allowed financial incentives that can be offered to the patients while still meeting the cost-
effectiveness goal for the interventions. Based on the medical effectiveness level of intervention, the range of financial 
incentives varies from $165-$1509 for INTV1 for medium values and $2066-$12041 for high values. Similar numbers 
are $597-$1269 for INTV2 for medium values and $1686-$11661 for high values. The numbers and range for INTV3 
for medium values are $563-$1235 and $5-$9980 for high values. 
   
Table 7: Maximum Allowed Financial Incentives  
Effectiveness 
Maximum Allowed Financial Incentives/Year with QoL 
INTV1 INTV2 INTV3 
Low Medium High Low Medium High Low Medium High 
25% 0 0 $2066 0 0 $1686 0 0 $5 
50% 0 $165 $5391 0 0 $5011 0 0 $3330 
75% 0 $837 $8716 0 $597 $8336 0 $563 $6655 
100% 0 $1509 $12041 0 $1269 $11661 0 $1235 $9980 
Low, Medium, and High range for following input parameters: 
Hospitalization, Number of days, Cost/day, Emergency visit rate, Emergency cost/visit, Probability of addiction, QoL 
 
DISCUSSION, CONCLUSION AND FUTURE WORK 
 
Prescription opioid abuse can lead to addiction, higher healthcare costs, and serious harm to patients. This abuse 
requires detoxification and hospitalization similar to a chronic condition. One of the major observations from the 
literature is that only 10% of people with opioid abuse get treatment or help.  Therefore, the opioid abuse is a major 
challenge for patients and family members, healthcare professionals, employers, regulators, and the society. There is 
a need for interventions at multiple levels before patients develop opioid addiction and require major treatment. In this 
paper, we focused on patient-level interventions, which are proactive and with some probabilities will be effective for 
some patients in preventing them from developing an opioid addiction. The interventions are (a) mobile reminders, 
(b) electronic monitoring of opioids, and (c) composite intervention. 
 
Using prescription opioid abuse and intervention data, we derived the healthcare cost of opioid abuse along with the 
cost of three interventions. Using an analytical model and ROI (Return on Investment) as a metric for cost-
effectiveness of interventions, we derived several results for all three interventions and various levels of effectiveness. 
We found that ROI is lower than 1 for low and medium values of our parameters, while it is much more favorable 
when the values of the parameters are set to high. When the value due to a potential improvement in Quality of Life 
was included, the ROI significantly improved for all three interventions. Further, we wanted to explore if the use of 
financial incentives will be suitable to improve the adoption of three interventions. For this, we computed the 
maximum allowed financial incentives that can be offered to the patients while still meeting the cost-effectiveness 
goal for the interventions. 
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We are planning to conduct a meta-analysis/contextual analysis of data from multiple sources to further evaluate the 
model. We are comparing the IT-based interventions with the non-IT interventions for opioid abuse. The scope for 
future research includes a randomized controlled trial (RCT) to evaluate the medical effectiveness of three proposed 
interventions. The research can be further extended to field studies using Health Promotion Model, Theory of 
Addiction, Theory of Adaptation, and other theories on drug abuse. 
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